Evidence map›Paper›PMID 33967040›Full record

ArticleJournal of Alzheimer's disease : JAD2021

The Behavioral and Psychological Symptoms of Dementia in Down Syndrome Scale (BPSD-DS II): Optimization and Further Validation.

Alain D Dekker, Aurora M Ulgiati, Henk Groen, Vincent A Boxelaar, Silvia Sacco, Ségolène Falquero, Angelo Carfi, Antonella di Paola, Bessy Benejam, Silvia Valldeneu and 18 more

Erratum issuedAbstract readValidation Study
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Early Markers for Dementia in the Intellectual Disability Population: A Systematic Literature Review.Journal of applied research in intellectual disabilities : JARID · 2025
    Pooled it
  3. Symptoms and age of prodromal Alzheimer's disease in Down syndrome: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  4. Pooled it
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

28 authors.

Alain D DekkerDepartment of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Aurora M UlgiatiDepartment of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Henk GroenDepartment of Epidemiology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Vincent A BoxelaarCenter for Information Technology, University of Groningen, Groningen, The Netherlands.
Silvia SaccoInstitut Jérôme Lejeune, Paris, France.
Ségolène FalqueroInstitut Jérôme Lejeune, Paris, France.
Angelo CarfiDepartment of Geriatrics, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.
Antonella di PaolaDepartment of Geriatrics, Fondazione Policlinico Universitario Gemelli IRCCS, Rome, Italy.
Bessy BenejamBarcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.
Silvia ValldeneuMemory Unit and Biomedical Research Institute Sant Pau (IIB Sant Pau), Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Roelie FopmaDepartment of Practice-oriented Scientific Research (PWO), Alliade Care Group, Heerenveen, The Netherlands.
Marjo OosterikAveleijn, Borne, The Netherlands.
Marloes HermelinkDe Twentse Zorgcentra, Enschede, The Netherlands.
Gonny BeugelsdijkIpse de Bruggen, Nieuwveen/Nootdorp, The Netherlands.
Mieke SchippersIpse de Bruggen, Nieuwveen/Nootdorp, The Netherlands.
Hepie HenstraNieuw Woelwijck, Sappemeer, The Netherlands.
Martine Scholten-KuiperPhiladelphia Zorg, Amersfoort, The Netherlands.
Judith Willink-VosSeverinus, Veldhoven, The Netherlands.
Lisa de RuiterSherpa, Baarn, The Netherlands.
Liesbeth WillemsSprank, Zwolle, The Netherlands.
Anneke Loonstra-de JongVanboeijen, Assen, The Netherlands.
Antonia M W CoppusDepartment of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Marleen TollenaereLaboratory of Neurochemistry and Behavior, Department of Biomedical Sciences and Institute Born-Bunge, University of Antwerp, Antwerp, Belgium.
Juan ForteaBarcelona Down Medical Center, Fundació Catalana Síndrome de Down, Barcelona, Spain.
Graziano OnderDepartment of Cardiovascular, Endocrine-metabolic Diseases and Aging, Istituto Superiore di Sanitá, Rome, Italy.
Anne-Sophie RebillatInstitut Jérôme Lejeune, Paris, France.
Debby Van DamDepartment of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Peter P De DeynDepartment of Neurology and Alzheimer Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Funding

The Role of Inflammation and NGF Dysfunction in the Evolution of Alzheimer Disease Pathology in Down Syndrome-RevisionRF1AG056850 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BUSCIGLIO, JORGE A, CUELLO, A CLAUDIO · 2018 to 2020
$5.9M
Tau pathology in Down syndrome and Alzheimer'sRF1AG061566 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER, MARGITTAI, MARTIN · 2019 to 2019
$3.4M
Biological Correlates of Alzheimer in Down Syndrome.R21AG056974 · NIA · UNIVERSITY OF DENVER (COLORADO SEMINARY) · PI GRANHOLM-BENTLEY, ANN-CHARLOTTE ESTHER · 2017 to 2018
$414k
NIA NIH HHS R21 AG056974NIA NIH HHS RF1 AG056850NIA NIH HHS RF1 AG061566
6 · The paper itself

Abstract

backgroundPeople with Down syndrome (DS) are at high risk to develop Alzheimer's disease dementia (AD). Behavioral and psychological symptoms of dementia (BPSD) are common and may also serve as early signals for dementia. However, comprehensive evaluation scales for BPSD, adapted to DS, are lacking. Therefore, we previously developed the BPSD-DS scale to identify behavioral changes between the last six months and pre-existing life-long characteristic behavior.

objectiveTo optimize and further study the scale (discriminative ability and reliability) in a large representative DS study population.

methodsOptimization was based on item irrelevance and clinical experiences obtained in the initial study. Using the shortened and refined BPSD-DS II, informant interviews were conducted to evaluate 524 individuals with DS grouped according to dementia status: no dementia (DS, N = 292), questionable dementia (DS + Q, N = 119), and clinically diagnosed dementia (DS + AD, N = 113).

resultsComparing item change scores between groups revealed prominent changes in frequency and severity for anxious, sleep-related, irritable, restless/stereotypic, apathetic, depressive, and eating/drinking behavior. For most items, the proportion of individuals displaying an increased frequency was highest in DS + AD, intermediate in DS + Q, and lowest in DS. For various items within sections about anxious, sleep-related, irritable, apathetic, and depressive behaviors, the proportion of individuals showing an increased frequency was already substantial in DS + Q, suggesting that these changes may serve as early signals of AD in DS. Reliability data were promising.

conclusionThe optimized scale yields largely similar results as obtained with the initial version. Systematically evaluating BPSD in DS may increase understanding of changes among caregivers and (timely) adaptation of care/treatment.

Indexed as

AdultAgedAnxietyDementiaDown SyndromeFemaleHumansIrritable MoodMaleMiddle AgedReproducibility of ResultsSymptom AssessmentAlzheimer’s diseasebehaviorbehavioral and psychological symptoms of dementiadementiaDown syndromeintellectual disabilitiesneuropsychiatric symptomstrisomy 21

Identifiers

PMID33967040
PMCPMC8293661

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.